Eliyahu Sharon Kalif, Executive Vice President and Chief Financial Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 153,251 shares of the company's stock on May 18, 2026. The shares were sold at a price of $35.61 per share, amounting to a total transaction value of approximately $5.46 million.
Insider sales can be motivated by a range of personal financial considerations, including portfolio diversification, tax